Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
前收盘价
US$70.78
+US$0.21 · +0.30%
盘后
US$70.78
US$0.00 · 0.00%
10月12日 16:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
日内区间
当前US$70.78
52周区间
当前US$70.78
盘中时间采用ET。市场数据可能有所延迟。
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
日内区间
当前US$70.78
52周区间
当前US$70.78
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 18.24亿 USD | 21.13亿 USD | 21.91亿 USD | 23.91亿 USD | 21.11亿 USD |
| 销货成本 | 12.75亿 USD | 14.95亿 USD | 15.23亿 USD | 15.61亿 USD | 14.41亿 USD |
| 毛利 | 5.49亿 USD | 6.18亿 USD | 6.68亿 USD | 8.3亿 USD | 6.7亿 USD |
| 研究与开发 | 5400万 USD | 5500万 USD | 5100万 USD | 5500万 USD | 5000万 USD |
| 销售、一般及管理费用 | 3.45亿 USD | 4.04亿 USD | 3.65亿 USD | 3.93亿 USD | 3.58亿 USD |
| 营业费用 | 13.24亿 USD | 6.44亿 USD | 4.96亿 USD | 4.97亿 USD | 4.78亿 USD |
| 利息收入 | 500万 USD | 1000万 USD | 1200万 USD | 400万 USD | 100万 USD |
| 利息支出 | 6300万 USD | 5300万 USD | 5700万 USD | 6600万 USD | 7300万 USD |
| 折旧和摊销 | 2.37亿 USD | 2.74亿 USD | 2.43亿 USD | 2.41亿 USD | 2.44亿 USD |
| 营业利润 | −7.75亿 USD | −2600万 USD | 1.72亿 USD | 3.33亿 USD | 1.92亿 USD |
| 净利润 | −8.45亿 USD | 1.69亿 USD | 1.78亿 USD | 9.27亿 USD | 2.2亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$78.29
上涨空间 10.61%年度分割调整后的每股现金分配。
US$1.65
2025年(完整年度)+40.4% 自从 2021
2026年(部分年度):US$1.255
US$1.175
2,021
US$1.305
2,022
US$1.49
2,023
US$1.60
2,024
US$1.65
2,025
US$1.255
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月1日 | US$0.42Quarterly | 2026年9月1日 | 2026年9月15日 |
股息 | 2026年6月1日 | US$0.42Quarterly | 2026年6月1日 | 2026年6月15日 |
股息 | 2026年2月27日 | US$0.415Quarterly | 2026年3月1日 | 2026年3月15日 |
股息 | 2025年12月1日 | US$0.415Quarterly | 2025年12月1日 | 2025年12月15日 |
股息 | 2025年8月29日 | US$0.415Quarterly | 2025年9月1日 | 2025年9月15日 |
股息 | 2025年5月30日 | US$0.415Quarterly | 2025年6月1日 | 2025年6月15日 |
除息 2026年9月1日
US$0.42
Quarterly
2026年9月1日登记 · 支付日 2026年9月15日
除息 2026年6月1日
US$0.42
Quarterly
2026年6月1日登记 · 支付日 2026年6月15日
除息 2026年2月27日
US$0.415
Quarterly
2026年3月1日登记 · 支付日 2026年3月15日
除息 2025年12月1日
US$0.415
Quarterly
2025年12月1日登记 · 支付日 2025年12月15日
除息 2025年8月29日
US$0.415
Quarterly
2025年9月1日登记 · 支付日 2025年9月15日
除息 2025年5月30日
US$0.415
Quarterly
2025年6月1日登记 · 支付日 2025年6月15日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.07亿0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM8549.58万0.11%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB7721.9万0.04%1853亿 USD0.03%US$288.16-0.46%
Avantis U.S. Small Cap Value ETFAVUV6575.3万0.21%308.51亿 USD0.25%US$119.94+0.25%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV6034.36万0.23%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Morningstar Small-Cap Value ETFVBR4906.23万0.07%682亿 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF3902.42万0.04%954亿 USD0.05%US$233.52-0.63%
Dimensional - US Targeted Value ETFDFAT3872.31万0.13%301.22亿 USD0.33%US$67.42+0.22%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Avantis U.S. Small Cap Value ETFAVUV
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。